Beating heart myocardial revascularization on extracorporeal circulation in patients with endstage coronary artery disease

被引:17
|
作者
Prifti, E
Bonacchi, M
Frati, G
Giunti, G
Proietti, P
Leacche, M
Massetti, M
Babatasi, G
Sani, G
机构
[1] Policlin Careggi, Div Cardiochirurg, I-50134 Florence, Italy
[2] IRCCS, NEUROMED, I-86077 Isernia, Pozzilli, Italy
[3] Univ Siena, Ist Chirurg Torac Cardiovasc & Tecnol Biomed, I-53100 Siena, Italy
[4] Dept Cardiothorac Surg, Caen, France
[5] Osped Maggiore Carita Novara, Div Cardiochirurg, Novara, Italy
来源
CARDIOVASCULAR SURGERY | 2001年 / 9卷 / 06期
关键词
end-stage coronary artery disease; on-pump/beating-heart; coronary artery bypass grafting;
D O I
10.1016/S0967-2109(01)00092-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate in a cohort of ESCAD patients (pts) the effects of on-pump/beating-heart versus conventional CABG in terms of early and mid-term survival and morbidity and LV function improvement. Methods: Between January 1993 and December 2000, 78 (Group I) ESCAD pts underwent on-pump/beating-heart surgery. Mean age in Group I was 66.2+/-6 (58-79), NYHA and CCS class were 3.2+/-0.6 and 3.3+/-0.4 respectively, Myocardial viability index 0.69+/-0.1 (%), LVEF (%) 24.8+/-4, LVEDP (mmHg) 28.1+/-5.8 and LVEDD(mm) 69.5+/-6. Group II consisted in 78 ESCAD patients undergoing conventional CABG selected in a randomized fashion from an age, sex, and LVEF corrected group of patients. Mean age in Group II was 65.7+/-5 (57-78), NYHA 3.1+/-0.7. CCS 3.4+/-0.8. LVEF(%) 25+/-5, LVEDP(mmHg) 27.9+/-4.4 and LVEDD(mm) 69.2+/-7.2. Results: Postoperatively, 5(7.7%) patients died in Group I versus 7(11.5%) patients in Group II (P >0.1). CPB time resulted to be in Group II patients (P = 0.001) and the mean distal anastomoses per patient was similar between groups (P = Ns). Perioperative AMI (P = 0.039). LCOS (P = 0.002), necessity for ultrafiltration (P = 0.018) and bleeding> 1000 ml (P = 0.029) were significantly higher in Group II. None of the Group I patients underwent surgical revision for bleeding versus 8(10.3%) patients in Group II (P = 0.011). At 6 months after surgery, the LV function improved significantly in Group I patients, demonstrated by an increased LVEF = 27.24(%)(P = 0.001), lower LVEDP = 26.4+/-3(mmHg)(P = 0.029) and LVEDD = 67+/-4 (mm) (P = 0.004) instead of a lower LVEDD = 66.8+/-6(mm) (P = 0.032) versus the preoperative data in Group [I. The actuarial survival at 1, 3 and 5 yr were 90, 82 and 71% in Group I and 89, 83 and 74% in Group II (P = Ns). Conclusion: In ESCAD patients who may poorly tolerate cardioplegic arrest, on-pump/beating-heart CABG may be an acceptable alternative associated with lower postoperative mortality and morbidity. Such a technique offers a better myocardial and renal protection associated with lower postoperative complications due to intraoperative hypoperfusion. (C) 2001 Published by Elsevier Science Ltd on behalf of The International Society for Cardiovascular Surgery.
引用
收藏
页码:608 / 614
页数:7
相关论文
共 50 条
  • [31] Surgical myocardial revascularization (CABG) in patients with pulmonary disease: Beating heart versus cardiopulmonary bypass
    Covino, E
    Santise, G
    Di Lello, F
    De Amicis, V
    Bonifazi, R
    Bellino, I
    Spampinato, N
    JOURNAL OF CARDIOVASCULAR SURGERY, 2001, 42 (01): : 23 - 26
  • [32] Myocardial revascularization in patients with coronary artery disease and end-stage renal disease
    Gradaus, F
    Schoebel, FC
    Ivens, K
    Heering, P
    Strauer, BE
    Leschke, M
    PERFUSION, 1996, 9 (12): : 428 - 432
  • [33] Kawasaki disease, myocardial infarction and coronary artery revascularization
    Wong, D
    Harder, J
    Jadavji, T
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (07) : 601 - 604
  • [34] MYOCARDIAL REVASCULARIZATION FOR CORONARY-ARTERY OCCLUSIVE DISEASE
    GEHA, AS
    LAKS, H
    HAMMOND, GL
    CONNECTICUT MEDICINE, 1980, 44 (06) : 344 - 348
  • [35] Mortality rate after coronary revascularization in heart failure patients with coronary artery disease
    Nader, Vanessa
    Matta, Anthony
    Kang, Ryeonshi
    Deney, Antoine
    Azar, Rania
    Rouzaud-Laborde, Charlotte
    Kunduzova, Oxana
    Itier, Romain
    Fournier, Pauline
    Galinier, Michel
    Carrie, Didier
    Roncalli, Jerome
    ESC HEART FAILURE, 2023, 10 (04): : 2656 - 2663
  • [36] Complete myocardial revascularization on the beating heart - Discussion
    Mattox, KL
    AMERICAN JOURNAL OF SURGERY, 1999, 178 (06): : 504 - 504
  • [37] Effect of rosuvastatin therapy and myocardial revascularization on angiogenesis in coronary artery disease patients
    Semenova, A. E.
    Sergienko, I. V.
    Masenko, V. P.
    Gabrusenko, S. A.
    Kukharchuk, V. V.
    Belenkov, Yu. N.
    KARDIOLOGIYA, 2007, 47 (11) : 4 - 8
  • [38] THE INFLUENCE OF MYOCARDIAL REVASCULARIZATION ON ANGIOGENIC GROWTH FACTORS IN CORONARY ARTERY DISEASE PATIENTS
    Sergienko, I. V.
    Merculov, E. V.
    Semenova, A. E.
    Masenko, V. P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 93 - 93
  • [39] Arterial hypertension in patients with coronary artery disease treated with surgical myocardial revascularization
    Vavlukis, M.
    Borozanov, V
    Georgievska-Ismail, L.
    Bosevski, M.
    Taneva, B.
    Kostova, N.
    Peovska, I
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2007, 108 (07): : 301 - 306
  • [40] Combined valve and myocardial revascularization on a beating heart in high risk patients
    Paolo Pepino
    Germano Coronella
    Piermario Oliviero
    Salvatore Giordano
    Raffaela Provenzano
    Agostino La Marca
    Antonio Contaldo
    Francesco Petteruti
    Mario Monaco
    Journal of Cardiothoracic Surgery, 10 (Suppl 1)